Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04295772
Brief Title: Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)

First Submitted : March 3, 2020
First Submitted that Met QC Criteria : March 3, 2020
First Posted : March 4, 2020

Last Update Submitted that Met QC Criteria : February 12, 2021
Last Update Posted : February 15, 2021